Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marchesoni

Showing results (351-360 of 521) with videos related to

Pageof 53
Sort By:
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issuesSalvatore D'Angelo, Carlo Palazzi, Fabrizio Cantini, et al.
Biomed Research International|August 12, 2014
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen RegistryMatteo Filippini, Chiara Bazzani, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|February 8, 2024
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trialsFabrizio Cantini, Antonio Marchesoni, Lucia Novelli, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthropathies. Part I: current evidence of efficacyCarlo Palazzi, Salvatore D'Angelo, Fabrizio Cantini, et al.
Clinical and Experimental Rheumatology|March 1, 1993
The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritisR Ranza, A Marchesoni, G Calori, et al.
Journal of Proteome Research|January 6, 2007
Oxidized transthyretin in amniotic fluid as an early marker of preeclampsiaCarlo Vascotto, Anna Maria Salzano, Chiara D'Ambrosio, et al.
Journal of Clinical Medicine|June 24, 2022
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR StudySalvatore D'Angelo, Carlo Salvarani, Francesca Marando, et al.
Medicina|April 27, 2021
Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfaGustavo Ferrari, Ricardo Reisin, Isaac Kisinovsky, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 16, 2016
Confined Catalytic Janus Swimmers in a Crowded Channel: Geometry-Driven Rectification Transients and Directional LockingHailing Yu, Andrii Kopach, Vyacheslav R Misko, et al.
The Journal of Rheumatology|June 3, 2016
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
Pageof 53

Showing results (351-360 of 521) with videos related to

Sort By:
Pageof 53
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issuesSalvatore D'Angelo, Carlo Palazzi, Fabrizio Cantini, et al.
Biomed Research International|August 12, 2014
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: long-term real-life data from the Lorhen RegistryMatteo Filippini, Chiara Bazzani, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|February 8, 2024
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trialsFabrizio Cantini, Antonio Marchesoni, Lucia Novelli, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthropathies. Part I: current evidence of efficacyCarlo Palazzi, Salvatore D'Angelo, Fabrizio Cantini, et al.
Clinical and Experimental Rheumatology|March 1, 1993
The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritisR Ranza, A Marchesoni, G Calori, et al.
Journal of Proteome Research|January 6, 2007
Oxidized transthyretin in amniotic fluid as an early marker of preeclampsiaCarlo Vascotto, Anna Maria Salzano, Chiara D'Ambrosio, et al.
Journal of Clinical Medicine|June 24, 2022
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR StudySalvatore D'Angelo, Carlo Salvarani, Francesca Marando, et al.
Medicina|April 27, 2021
Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfaGustavo Ferrari, Ricardo Reisin, Isaac Kisinovsky, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 16, 2016
Confined Catalytic Janus Swimmers in a Crowded Channel: Geometry-Driven Rectification Transients and Directional LockingHailing Yu, Andrii Kopach, Vyacheslav R Misko, et al.
The Journal of Rheumatology|June 3, 2016
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
Pageof 53